We are live on ! Find out more
ONC

BeOne Medicines Ltd

221 hedge funds and large institutions have $8.11B invested in BeOne Medicines Ltd in 2019 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 66 increasing their positions, 76 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 19

32% more capital invested

Capital invested by funds: $6.12B → $8.11B (+$1.99B)

13% more funds holding

Funds holding: 196221 (+25)

0.13% less ownership

Funds ownership: 6.4%6.27% (-0.13%)

10% less funds holding in top 10

Funds holding in top 10: 109 (-1)

13% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 76

72% less call options, than puts

Call options by funds: $16.8M | Put options by funds: $59.2M

Holders
221
Holders Change
+25
Holders Change %
+12.76%
% of All Funds
4.35%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.18%
New
50
Increased
66
Reduced
76
Closed
19
Calls
$16.8M
Puts
$59.2M
Net Calls
-$42.3M
Net Calls Change
-$37.2M
Name Holding Trade Value Shares
Change
Change in
Stake
CSS
76
Cubist Systematic Strategies
Connecticut
$4.27M +$4.28M +25,745 New
TD Asset Management
77
TD Asset Management
Ontario, Canada
$4.17M -$596K -3,585 -12%
Citadel Advisors
78
Citadel Advisors
Florida
$3.54M +$3.55M +21,375 New
PAMU
79
Pictet Asset Management (UK)
United Kingdom
$3.44M +$16.4M +98,452 +58%
RPAM
80
Rhenman & Partners Asset Management
Sweden
$3.31M +$3.32M +20,000 New
Canada Life
81
Canada Life
Manitoba, Canada
$3.26M -$449K -2,700 -12%
AAMU
82
Amundi Asset Management US
Massachusetts
$3.22M +$156K +937 +5%
PAM
83
Panagora Asset Management
Massachusetts
$3.19M
UBS Group
84
UBS Group
Switzerland
$3.19M -$1.64M -9,880 -34%
Royal Bank of Canada
85
Royal Bank of Canada
Ontario, Canada
$3.1M +$324K +1,951 +12%
Public Sector Pension Investment Board (PSP Investments)
86
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$3.03M -$111K -667 -4%
B
87
Barings
North Carolina
$2.96M -$145K -872 -5%
GC
88
Guggenheim Capital
Illinois
$2.81M +$2.81M +16,926 New
JP Morgan Chase
89
JP Morgan Chase
New York
$2.77M +$246K +1,481 +10%
Aviva
90
Aviva
United Kingdom
$2.58M +$50.7K +305 +2%
Qube Research & Technologies (QRT)
91
Qube Research & Technologies (QRT)
United Kingdom
$2.48M +$2.49M +14,985 New
IBT
92
International Biotechnology Trust
United Kingdom
$2.32M +$2.33M +14,000 New
Bank of Montreal
93
Bank of Montreal
Ontario, Canada
$2.24M +$237K +1,426 +12%
Susquehanna International Group
94
Susquehanna International Group
Pennsylvania
$2.22M -$1.44M -8,640 -39%
Aberdeen Group
95
Aberdeen Group
United Kingdom
$2.03M -$379K -2,282 -16%
Public Employees Retirement Association of Colorado
96
Public Employees Retirement Association of Colorado
Colorado
$1.94M
VIA
97
Vident Investment Advisory
Georgia
$1.89M -$428K -2,575 -18%
XK
98
Xact Kapitalforvaltning
Sweden
$1.84M +$1.84M +11,100 New
LCM
99
Laurion Capital Management
New York
$1.79M +$1.79M +10,800 New
OAM
100
Oxford Asset Management
United Kingdom
$1.74M -$824K -4,960 -32%

ONC Hedge Fund Activity: Q4 2019 in Review

221 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q4 2019, worth a combined $8.11B — up 32% from $6.12B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new ONC positions and 19 closed out — a net gain of 31 holders — while 66 added to existing stakes and 76 trimmed.

The largest buyer was Capital International Investors, adding an estimated $166M. The largest seller was Myriad Asset Management, exiting entirely with an estimated $120M sold.

  • 221 institutional investors held BeOne Medicines Ltd (ONC) as of Q4 2019, up from 196 in Q3 2019.
  • Funds reported $8.11B of BeOne Medicines Ltd stock for Q4 2019, up 32% quarter-over-quarter.
  • 50 funds opened new BeOne Medicines Ltd positions in Q4 2019 and 19 closed out, a net change of +31 holders.
  • The largest BeOne Medicines Ltd buyer in Q4 2019 was Capital International Investors, an estimated $166M added.
  • The largest BeOne Medicines Ltd seller in Q4 2019 was Myriad Asset Management, an estimated $120M sold.

Based on aggregated 13F filings for Q4 2019.